Shedding dynamics of Epstein-Barr virus: A type 1 carcinogen

Archives of Oral Biology

Volumn 55, Issue 9, 2010, Pages 639-647

  Perera, R A P M ^a   Samaranayake, L P ^a   Tsang, C S P ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Carcinogen; Epstein Barr virus; Shedding

Indexed keywords

HUMAN HERPESVIRUS 4;

EID: 78149360292     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2010.06.009     Document Type: Review

References (74)

1. Proceedings of the IARC working group on the evaluation of carcinogenic risks to humans. Epstein-Barr virus and Kaposi's sarcoma Herpesvirus/Human herpesvirus 8. Lyon, France, 17-24 June 1997. IARC Monogr Eval Carcinog Risks Hum 1997; 70: 1-492.
2. Niederman JC, Evans AS, Subrahmanyan L, McCollum RW. Prevalence, incidence and persistence of Eb Virus antibody in young adults. N Engl J Med 1970; 282: 361-5.
3. Hoagland RJ. The transmission of infectious mononucleosis. Am J Med Sci 1955; 229: 262-72.
4. Pegtel DM, Middeldorp J, Thorley-Lawson DA. Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers. J Virol 2004; 78: 12613-24.
5. Sixbey JW, Lemon SM, Pagano JS. A second site for EpsteinBarr virus shedding: the uterine cervix. Lancet 1986; 2: 1122-4.
6. Israele V, Shirley P, Sixbey JW. Excretion of the Epstein-Barr virus from the genital tract of men. J Infect Dis 1991; 163: 1341-3.
7. Thomas R, Macsween KF, McAulay K, Clutterbuck D, Anderson R, Reid S, et al. Evidence of shared Epstein-Barr viral isolates between sexual partners, and low level EBV in genital secretions. J Med Virol 2006; 78: 1204-9.
8. Junker AK, Thomas EE, Radcliffe A, Forsyth RB, Davidson AG, Rymo L. Epstein-Barr virus shedding in breast milk. Am J Med Sci 1991; 302: 220-3.
9. Hadinoto V, Shapiro M, Sun CC, Thorley-Lawson DA. The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 2009; 5: e1000496.
10. Walling DM, Ray AJ, Nichols JE, Flaitz CM, Nichols CM. Epstein-Barr virus infection of Langerhans cell precursors as a mechanism of oral epithelial entry, persistence, and reactivation. J Virol 2007; 81: 7249-68.
11. Walling DM, Flaitz CM, Hosein FG, Montes-Walters M, Nichols CM. Effect of Epstein-Barr virus replication on Langerhans cells in pathogenesis of oral hairy leukoplakia. J Infect Dis 2004; 189: 1656-63.
12. Hoover SE, Kawada J, Wilson W, Cohen JI. Oropharyngeal shedding of Epstein-Barr virus in the absence of circulating B cells. J Infect Dis 2008; 198: 318-23.
13. Genberg H, Hansson A, Wernerson A, Wennberg L, Tyden G. Pharmacodynamics of rituximab in kidney allotransplantation. Am J Transplant 2006; 6: 2418-28.
14. Maloney DG, Liles TM, Czerwinski DK, Waldichuk C, Rosenberg J, Grillo-Lopez A, et al. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood 1994; 84: 2457-66.
15. Ling PD, Lednicky JA, Keitel WA, Poston DG, White ZS, Peng R, et al. The dynamics of herpesvirus and Polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. J Infect Dis 2003; 187: 1571-80.
16. Mehta SK, Pierson DL, Cooley H, Dubow R, Lugg D. EpsteinBarr virus reactivation associated with diminished cellmediated immunity in antarctic expeditioners. J Med Virol 2000; 61: 235-40.
17. van Esser JW, van der Holt B, Meijer E, Niesters HG, Trenschel R, Thijsen SF, et al. Epstein-Barr virus (Ebv) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 2001; 98: 972-8.
18. Ikuta K, Satoh Y, Hoshikawa Y, Sairenji T. Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children. Microbes Infect 2000; 2: 115-20.
19. National Center for Infectious Diseases Centers for Disease Control and Prevention. Epstein-Barr virus and infectious mononucleosis. Available at January 01, 2008 [cited; Available from: http://www.cdc.gov/ncidod/diseases/ ebv.htm.
20. Aitcheson CT, Wilson GL, Ferrell PB, Tan EM. Frequency of transforming Epstein-Barr virus in oropharyngeal secretions of rheumatoid arthritis patients. Interuirology 1983; 19: 135-43.
21. Chang RS, Lewis JP, Abildgaard CF. Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population. N Engl J Med 1973; 289: 1325-9.
22. Gasparoni A, Ciardelli L, Avanzini A, Castellazzi AM, Carini R, Rondini G, et al. Age-related changes in intracellular Th1/ Th2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults. Biol Neonate 2003; 84: 297-303.
23. Milagres A, Dias EP, Tavares Ddos S, Cavalcante RM, Dantas VA, de Oliveira SP, et al. Prevalence of oral hairy leukoplakia and epithelial infection by Epstein-Barr virus in pregnant women and diabetes mellitus patients- cytopathologic and molecular study. Mem Inst Oswaldo Cruz 2007; 102: 159-64.
24. Cox AJ, Gleeson M, Pyne DB, Saunders PU, Clancy RL, Fricker PA. Valtrex therapy for Epstein-Barr virus reactivation and upper respiratory symptoms in elite runners. Med Sci Sports Exerc 2004; 36: 1104-10.
25. Gleeson M, Pyne DB, Austin JP, Lynn Francis J, Clancy RL, McDonald WA, et al. Epstein-Barr virus reactivation and upper-respiratory illness in elite swimmers. Med Sci Sports Exerc 2002; 34: 411-7.
26. Sumaya CV, Ench Y. Epstein-Barr virus infections in families: the role of children with infectious mononucleosis. J Infect Dis 1986; 154: 842-50.
27. Niederman JC, Miller G, Pearson HA, Pagano JS, Dowaliby JM. Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx. N Engl J Med 1976; 294: 1355-9.
28. Haque T, Thomas JA, Parratt R, Hunt BJ, Yacoub MH, Crawford DH. A prospective study in heart and lung transplant recipients correlating persistent Epstein-Barr virus infection with clinical events. Transplantation 1997; 64: 1028-34.
29. Ambinder RF, Wingard JR, Burns WH, Hayward SD, Saral R, Perry HR, et al. Detection of Epstein-Barr virus DNA in mouthwashes by hybridization. J Clin Microbiol 1985; 21: 353-6.
30. Yao QY, Rickinson AB, Gaston JS, Epstein MA. In Vitro Analysis of the Epstein-Barr virus: host balance in longterm renal allograft recipients. Int J Cancer 1985; 35: 43-9.
31. Preiksaitis JK, Diaz-Mitoma F, Mirzayans F, Roberts S, Tyrrell DL. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder. J Infect Dis 1992; 166: 986-94.
32. Kunimoto M, Tamura S, Tabata T, Yoshie O. One-step typing of Epstein-Barr virus by polymerase chain reaction: predominance of type 1 virus in Japan J Gen Virol 1992; 73(Pt 2): 455-61.
33. Yoda K, Sata T, Kurata T, Aramaki H. Oropharyngotonsillitis associated with nonprimary Epstein-Barr virus infection. Arch Otolaryngol Head Neck Surg 2000; 126: 185-93.
34. Lucht E, Biberfeld P, Linde A. Epstein-Barr virus (EBV) DNA in saliva and EBV serology of HIV-1-infected persons with and without hairy leukoplakia. J Infect 1995; 31: 189-94.
35. Miller CS, Berger JR, Mootoor Y, Avdiushko SA, Zhu H, Kryscio RJ. High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J Clin Microbiol 2006; 44: 2409-15.
36. Ammatuna P, Campisi G, Giovannelli L, Giambelluca D, Alaimo C, Mancuso S, et al. Presence of Epstein-Barr virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV-infected and renal transplant patients. Oral Dis 2001; 7: 34-40.
37. Griffin E, Krantz E, Selke S, Huang ML, WaId A. Oral mucosal reactivation rates of herpesviruses among HIV-I seropositive persons. J Med Virol 2008; 80: 1153-9.
38. Fox RI, Luppi M, Kang HI, Pisa P. Reactivation of EpsteinBarr virus in Sjogren's Syndrome. Springer Semin Immunopathol 1991; 13: 217-31.
39. Newkirk MM, Duffy KN, Paleckova A, Ivaskova E, Galianova A, Seeman J, et al. Herpes viruses in multicase families with rheumatoid arthritis. J Rheumatol 1995; 22: 2055-61.
40. Sarid O, Anson O, Yaari A, Margalith M. Epstein-Barr Virus specific salivary antibodies as related to stress caused by examinations. J Med Virol 2001; 64: 149-56.
41. Uchakin PN, Stowe RP, Paddon-Jones D, Tobin BW, Ferrando AA, Wolfe RR. Cytokine secretion and latent herpes virus reactivation with 28 days of horizontal hypokinesia. Auiat Space Environ Med 2007; 78: 608-12.
42. Woodman CB, Collins SI, Vavrusova N, Rao A, Middeldorp JM, Kolar Z, et al. Role of sexual behavior in the acquisition of asymptomatic Epstein-Barr virus infection: a longitudinal study. Pediatr Infect Dis J 2005; 24: 498-502.
43. Enbom M, Strand A, Falk KI, Linde A. Detection of EpsteinBarr Virus, but not human herpesvirus 8, DNA in cervical secretions from Swedish women by real-time polymerase chain reaction. Sex Transm Dis 2001; 28: 300-6.
44. Andersson-Ellstrom A, Bergstrom T, Svennerholm B, Milsom I. Epstein-Barr Virus DNA in the uterine cervix of teenage girls. Acta Obstet Gynecol Scand 1997; 76: 779-83.
45. Matias-Guiu X, Komminoth P, Prat J. Absence of EpsteinBarr virus DNA in lymphoepithelioma-like carcinoma of the the uterine cervix. Am J Clin Pathol 1994; 101: 117.
46. Gantt S, Carlsson J, Shetty AK, Seidel KD, Qin X, Mutsvangwa J, et al. Cytomegalovirus and Epstein-Barr virus in breast milk are associated with HIV-1 shedding but not with mastitis. Aids 2008; 22: 1453-60.
47. Willoughby CE, Baker K, Kaye SB, Carey P, O'Donnell N, Field A, et al. Epstein-Barr virus (Types 1 and 2) in the tear film in Sjogren's syndrome and HIV infection. J Med Virol 2002; 68: 378-83.
48. Lee-Wing MW, Hodge WG, Diaz-Mitoma F. The prevalence of herpes family virus DNA in the conjunctiva of patients positive and negative for human immunodeficiency virus using the polymerase chain reaction. Ophthalmology 1999; 106: 350-4.
49. Landau Z, Gross R, Sanilevich A, Friedmann A, MitraniRosenbaum S. Presence of infective Epstein-Barr virus in the urine of patients with infectious mononucleosis. J Med Virol 1994; 44: 229-33.
50. Gavioli R, Kurilla MG, de Campos-Lima PO, Wallace LE, Dolcetti R, Murray RJ, et al. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J Virol 1993; 67: 1572-8.
51. de Campos-Lima PO, Gavioli R, Zhang QJ, Wallace LE, Dolcetti R, Rowe M, et al. HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly All+ population. Science 1993; 260: 98-100.
52. Tiwawech D, Srivatanakul P, Karalak A, Ishida T. Association between EBNA2 and LMP1 subtypes of EpsteinBarr virus and nasopharyngeal carcinoma in Thais. J Clin Virol 2008; 42: 1-6.
53. Thornburg NJ, Kulwichit W, Edwards RH, Shair KH, Bendt KM, Raab-Traub N. LMP1 signaling and activation of NFkappaB in LMP1 transgenic mice. Oncogene 2006; 25: 288-97.
54. van Kooij B, Thijsen SF, Meijer E, Niesters HG, van Esser JW, Cornelissen JJ, et al. Sequence analysis of EBV DNA isolated from mouth washings and PBMCs of healthy individuals and blood of EBV-LPD patients. J Clin Virol 2003; 28: 85-92.
55. Lung ML, Lam WP, Sham J, Choy D, Yong-Sheng Z, Guo HY, et al. Detection and prevalence of the "F" variant of Epstein-Barr virus in southern China. Virology 1991; 185: 67-71.
56. Schmidt-Westhausen A, Gelderblom HR, Hetzer R, Reichart PA. Demonstration of Epstein-Barr virus in scrape material of lateral border of tongue in heart transplant patients by negative staining electron microscopy. J Oral Pathol Med 1991; 20: 215-7.
57. Polack A, Hartl G, Zimber U, Freese UK, Laux G, Takaki K, et al. A complete set of overlapping cosmid clones of MABA virus derived from nasopharyngeal carcinoma and its similarity to other Epstein-Barr virus isolates. Gene 1984; 27: 279-88.
58. Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, et al. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991; 72(Pt 10): 2399-409.
59. Bouzid M, Sheng W, Buisson M, Bouguermouh A, Morand P, Seigneurin JM, et al. Different distribution of H1-H2 Epstein-Barr virus variant in oropharyngeal virus and in biopsies of Hodgkin's disease and in nasopharyngeal carcinoma from Algeria. Int J Cancer 1998; 77: 205-10.
60. Gutierrez MI, Raj A, Spangler G, Sharma A, Hussain A, Judde JG, et al. Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells. J Gen Virol 1997; 78(Pt 7): 1663-70.
61. Snudden DK, Smith PR, Lai D, Ng MH, Griffin BE. Alterations in the structure of the EBV nuclear antigen. EBNA1, in epithelial cell tumours. Oncogene 1995; 10: 1545-52.
62. Mai SJ, Ooka T, Li DJ, Zeng MS, Jiang RC, Yu XJ, et al. Functional advantage of npc-related v-Val subtype of Epstein-Barr virus nuclear antigen 1 compared with prototype in epithelial cell line. Oncol Rep 2007; 17: 141-6.
63. Sacaze C, Henry S, Icart J, Mariame B. Tissue specific distribution of Epstein-Barr virus (EBV) BZLF-1 gene variants in nasopharyngeal carcinoma (NPC) bearing patients. Virus Res 2001; 81: 133-42.
64. Triantos D, Leao JC, Porter SR, Scully CM, Teo CG. Tissue distribution of Epstein-Barr virus genotypes in hosts coinfected by HIV. Aids 1998; 12: 2141-6.
65. Wedderburn N, Edwards JM, Desgranges C, Fontaine C, Cohen B, de The G. Infectious mononucleosis-like response in common marmosets infected with Epstein-Barr virus. J Infect Dis 1984; 150: 878-82.
66. Cox C, Chang S, Karran L, Griffin B, Wedderburn N. Persistent Epstein-Barr virus infection in the common marmoset (Callithrix Jacchus). J Gen Virol 1996; 77(Pt 6): 1173-80.
67. Cox C, Naylor BA, Mackett M, Arrand JR, Griffin BE, Wedderburn N. Immunization of common marmosets with Epstein-Barr virus (EBV) envelope glycoprotein gp340: effect on viral shedding following EBV challenge. J Med Virol 1998; 55: 255-61.
68. Niedobitek G, Agathanggelou A, Finerty S, Tierney R, Watkins P, Jones EL, et al. Latent Epstein-Barr virus infection in cottontop tamarins. A possible model for Epstein-Barr virus infection in humans. Am J Pathol 1994; 145: 969-78.
69. Borza CM, Hutt-Fletcher LM. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 2002; 8: 594-9.
70. Molesworth SJ, Lake CM, Borza CM, Turk SM, Hutt-Fletcher LM. Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells. J Virol 2000; 74: 6324-32.
71. Oda T, Imai S, Chiba S, Takada K. Epstein-Barr virus lacking glycoprotein gp85 cannot infect B cells and epithelial cells. Virology 2000; 276: 52-8.
72. Nemerow GR, Mold C, Schwend VK, Tollefson V, Cooper NR. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. J Virol 1987; 61: 1416-20.
73. Lowhagen GB, Bergbrant IM, Bergstrom T, Ryd W, Voog E. PCR detection of Epstein-Barr virus, herpes simplex virus and human papillomavirus from the anal mucosa in HIV-seropositive and HIV-seronegative homosexual men. Int J STD AIDS 1999; 10: 615-8.
74. McManus TE, Marley AM, Baxter N, Christie SN, Elborn JS, O'Neill HJ, et al. High levels of Epstein-Barr virus in COPD. Eur Respir J 2008; 31: 1221-6.